rediff.com

NewsApp (Free)

Read news as it happens
Download NewsApp

Available on  

Rediff News  All News 
Rediff.com  » Sports » Ashwini, Priyanka's 'B' samples positive

Ashwini, Priyanka's 'B' samples positive

July 11, 2011 15:38 IST

Dope-tainted athlete Ashwini Akkunji's London Olympics dreams are virtually over, as her 'B' sample also tested positive for anabolic steroids.

She now faces the prospect of a two-year ban.

Another quarter-miler, Priyanka Pawar's 'B' sample also tested positive for anabolic steroids.

Ashwini and Priyanka had their 'B' samples tested on Thursday at the National Dope Testing Laboratory in Delhi and the results, which came in on Monday, confirmed the presence of methandionone in them.

Ashwini Akkunji"We have received papers from the NADA that both Ashwini and Priyanka's 'B' samples have tested positive for the same anabolic steroids found in their 'A' sample," Athletics Federation of India Director M L Dogra said.

Ashwini and Priyanka, who were caught for doping just hours before they were to leave the country for the July 7-10 Asian Athletics Championships in Japan, will now be heard by a NADA Disciplinary Panel.

Both have been provisionally suspended by the AFI pending the decision by the NADA panel.

The maximum punishment, if found guilty, is a two-year ban, as both committed their first dope offence.

This will make Ashwini, double gold medallist at the Asian Games -- in the 400m hurdles and 4x400m relay – virtually out of contention for a 2012 Olympics berth. She is yet to qualify for the London Olympics.

She will also miss the August 27-September 4 World Championships in Daegue, South Korea, though she has qualified for the 400m hurdles.

Ashwini's gold-winning relay team-mates Mandeep Kaur and Sini Jose had also tested positive for anabolic steroids in one of the worst doping scandals in Indian sport.

Quarter-milers, Jauna Murmu and Tiana Mary Thomas, long jumper Hari Krishnan Muralidharan and Sonia are the others caught for using anabolic steroids.

© Copyright 2013 PTI. All rights reserved. Republication or redistribution of PTI content, including by framing or similar means, is expressly prohibited without the prior written consent.